ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near Boston, MA, USA:

Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer

This research study is studying a combination of drugs as a possible treatment for EGFR-Mutated Advanced Lung Cancer.The names of t...

Enrolling
Lung Cancer
Drug: Niraparib
Drug: Osimertinib

Phase 1

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

This research study is studying a combination of drugs as a possible treatment for EGFR mutation-positive lung cancer.The drugs inv...

Active, not recruiting
Lung Cancer
Drug: EGF816
Drug: Gefitinib

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

This research study is studying a combination of two drugs as a possible treatment for Non-Small Cell Lung Cancer (NSCLC) with an E...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Gefitinib
Drug: Osimertinib

Phase 1, Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 1 other location

This research study is evaluating the combination of olaparib and temozolomide as a possible treatment for Small Cell Lung Cancer....

Active, not recruiting
Small Cell Lung Cancer
Drug: Temozolomide
Drug: Olaparib

Phase 1, Phase 2

Zofia Piotrowska

Boston, Massachusetts, United States and 2 other locations

This trial is being conducted as a possible treatment for lung cancer with a specific change in the KRAS gene.The drugs involved in...

Active, not recruiting
Lung Cancer
Drug: Palbociclib
Drug: Binimetinib

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Boston, Massachusetts, United States and 83 other locations

chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Osimertinib
Drug: Carboplatin

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Boston, Massachusetts, United States and 15 other locations

This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Trastuzumab deruxtecan

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Boston, Massachusetts, United States and 47 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Boston, Massachusetts, United States and 43 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a
Drug: Docetaxel

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Boston, Massachusetts, United States and 205 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems